Skip to main content
. 2019 Mar 19;34(5):1050–1057. doi: 10.3904/kjim.2018.063

Figure 1.

Figure 1.

Flow diagram of cutaneous adverse drug reactions (CADRs) associated with peripheral blood eosinophilia during anti-tuberculosis (TB) treatment. WBC, white blood cell.